id: NEW:flexible_dosing_schedule_availability_to_sud_treatment_entry_rate
name: Flexible Dosing Schedule Availability â†’ SUD Treatment Entry Rate
from_node:
  node_id: NEW:flexible_dosing_schedule_availability
  node_name: Flexible Dosing Schedule Availability
to_node:
  node_id: sud_treatment_entry_rate
  node_name: SUD Treatment Entry Rate
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Community pharmacy model offers flexible dosing times compared to traditional clinic-based
  programs'
- 'Step 2: Flexibility accommodates participants'' work, family, and other life obligations that create
  treatment barriers'
- 'Step 3: Co-location allows patients to pick up other medications simultaneously, increasing convenience'
- 'Step 4: Reduced structural barriers facilitate initial treatment engagement and sustained participation'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Tamara Mihic et al. 2025. "Community Pharmacy-Based Injectable Opioid Agonist Treatment:
    Findings From a Canadian Pilot Program.." https://doi.org/10.1111/dar.70062'
  supporting_citations:
  - Additional citations require full-text access
  doi: 10.1111/dar.70062
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Participants identified flexible dosing times and the ability to obtain other medications
  at the same location as key strengths of the pharmacy-based iOAT model, suggesting these structural
  features enhance treatment accessibility and engagement.
quantitative_effects:
  sample_size: 176
moderators:
- name: employment_status
  direction: strengthens
  strength: moderate
  description: Working individuals particularly benefit from flexible dosing that can accommodate employment
    schedules
structural_competency:
  equity_implications: Traditional OUD treatment programs often have rigid schedules that conflict with
    employment, childcare, and other responsibilities, creating structural barriers that disproportionately
    affect low-income and working-class populations. The pharmacy model addresses these systemic access
    issues.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.811164'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
